| | |
| 14:15-15:15 | Session: epidemiology, subtypes, regional issues Issues
about testing for HIV infection in pregnant women
Gabriela Elena Iliescu
County Emergency Clinical Hospital Craiova
Survival of HIV infected
patients treated with HAART in a resource-limited setting: the
belgrade cohort study
Djordje Jevtovic
Institute of Infective and Tropical Disease Dr Kosta Todorovic,
School of Medicine, University of Belgrade, Belgrade, Serbia
HIV/AIDS infection in the
Republic of Moldova
Ina Bîstrițchi
State University of Medicine and Pharmacy "N.Testemitanu", Center
for Health Policies and Studies
Antiretroviral treatment at
pregnant women: effects on newborns
Mariana Mărdărescu
National Institute for Infectious Diseases "Prof. Dr. Matei Bals",
Bucharest
|
| 15:15-15:30 | Short presentation NovaIntermed |
| 15:30-16:00 | Keynote lecture: François Simon, MD
Biological and Clinical Consequences of the HIV Diversity |
| 16:00-16:15 | Coffee break |
| 16:15-17:15 | Symposium Brystol-Myers Squibb:
The Challenge of Achiving Long Time Undetectable Viremia
Chairman: Adrian Streinu-Cercel, MD, PhD
- Current HIV guidelines and perspecives, Irina Dumitru
- HIV and chronic inflamation, Adrian Streinu-Cercel
- Achiving Long Time Undetectable Viremia, Carmen Dorobăț |
| 17:15-17:30 | Official opening:
Adrian Streinu-Cercel, MD, PhD |
| 17:30-18:00 | Keynote lecture: Douglas Richman, MD
The Challenge of Eradicating the Latent HIV Reservoir |
| 18:00-19:00 | Symposium Janssen:
NNRTI Resistance and Rational use of New NNRTIs
Chairman: Adrian Streinu-Cercel, MD, PhD |
| 20:00 | Welcome Cocktail |
|
| | |
| 09:00-09:30 | Keynote lecture: Annemarie Wensing, MD, PhD
HIV Tropism: Impact on Pathogenesis and Clinical Management |
| 09:30-10:30 | Session: resistance, tropismDeep
sequencing to detect minority resistance mutations in patients
with suboptimal adherence
Simona Paraschiv
Molecular Diagnostics, Matei Bals National Institute for
Infectious Diseases, Bucharest, Romania
The prevalence and patterns of
genotypic resistance to antiretroviral drugs in patients with
virological failure from Croatia; 2008-2010
Ana Planinic
University Hospital for Infectious Diseases "dr. Fran Mihaljevic",
Zagreb, Croatia. Department for molecular diagnostics and flow
citometry
Ten years survey of HIV-1
genetic diversity in Serbia
Marina Siljic
University of Belgrade Faculty of Medicine
Decreasing prevalence of
antiretroviral resistance mutations in Romania HIV patients
Florea Dragos
Prof Dr Matei Bals National Institute for Infectious Diseases,
Romania
Analyze of available treatment
options in a group of multiexperienced patients with
parenterally-aquired HIV-infection
Roxana Radoi
Dr. Victor Babes Hospital for Infectious and Tropical Diseases,
Bucharest, Romania
|
| 10:30-10:45 | Coffee break |
| 10:45-11:45 | Symposium GlaxoSmithKline:
Managing ARVs between Initiation and Switch
- The role of newer third agents in HIV treatment - Mike Youle, HIV Research Royal Free Centre for HIV Medicine, London, UK
- HLA 5701 testing in newly diagnosed patients - Dan Otelea, Prof Dr Matei Bals National Institute for Infectious Diseases, Romania |
| 11:45-12:15 | Keynote lecture: Mike Youle, MD, ChB
Co-morbidities and How to Deal with Them |
| 12:15-13:00 | Symposium Teva Pharmaceuticals:
New Challenges in Combating IFI in 2012
- Combating IFI with ABELCET 9amphotericin B lipid complex) – CLEAR registry data, efficacy and safety data
Adrian Streinu-Cercel, MD, PhD, Prof Dr Matei Bals National Institute for Infectious Diseases, Romania
- Using ABELCET in pediatric population – different challenges, clinical and safety data
Anca Streinu-Cercel, MD, PhD, Prof Dr Matei Bals National Institute for Infectious Diseases, Romania |
| 13:00-14:00 | Lunch |
| 14:00-14:30 | Symposium Boehringer Ingelheim:
Nevirapine Reloaded
Chairman: Adrian Streinu-Cercel, MD, PhD |
| 14:30-15:30 | Session: Comorbidities: infectious Anal
HPV infection in HIV-positive and HIV-negative men who have sex
with men in Slovenia
Poljak Mario
Institute of Microbiology and Immunology, Faculty of Medicine,
University of Ljubljana, Slovenia
Tuberculous meningitis in
HIV-infected patients
Adriana Hristea
Prof. Dr. Matei Bals National Institute for Infectious Diseases
Low prevalence of hepatitis C
infection among HIV-infected individuals in Slovenia: a
nation-wide study, 1986-2011
Seme Katja
Institute of Microbiology and Immunology, Faculty of Medicine,
University of Ljubljana, Slovenia
TB in HIV positive adolescents
and adults
Simona Claudia Cambrea
Infectious Diseases Clinic, Faculty of Medicine, "Ovidius"
University
|
| 15:30-16:30 | Symposium Merck Sharp & Dohme:
Treating HIV now for longterm benefits
- Comorbidities in HIV. Choosing the right treatment for the right patient
Mark Nelson, Chelsea and Westminster Hospital, London, UK
- Longterm benefits of adherence
Odette Chirila, Prof Dr Matei Bals National Institute for Infectious Diseases, Romania |
| 16:30-16:45 | Coffee break |
| 16:45-17:15 | Keynote lecture: Mark Wainberg, PhD
Hot Issues in Drug Resistance |
| 17:15-18:15 | Session: Comorbidities: non-infectious Serum
adiponectin and insulin resistance in a cohort of HIV-1 positive
patients undergoing antiretroviral therapy
Catalin Tiliscan
Carol Davila University of Medicine and Pharmacy, Bucharest, Prof.
Dr. Matei Bals National Institute of Infectious Diseases,
Bucharest
Metabolic syndrome in HIV
infected patients: effects of antiretroviral therapy
Gordana Dragovic
Institute of Pharmacology, Clinical Pharmacology and Toxicology,
School of Medicine, University of Belgrade, Belgrade, Serbia
Adipocytokines profile in HIV
treatment-experienced patients with lipodystrophy syndrome
Daniela Munteanu
Matei Bals National Institute of Infectious Diseases, Bucharest
Effects of adherence on the
immunovirological and metabolic profile of HIV positive patients
Incze Andrea
Infectious Diseases Clinic Tg. Mures, UMPh Tg. Mures
Dyslipidemia in young adults
horizontally infected with HIV-1 during infancy
Augustin Cupșa
University of Medicine and Pharmacy from Craiova, Romania
|
| 18:15-19:15 | Symposium Roche:
HIV/AIDS Therapy - a successuful strategy
Chairman: Adrian Streinu-Cercel, MD, PhD |
| 20:00 | Gala Dinner |
|
| | |
| 08:00-09:00 | Clinical Cases Workshop:
Scott Letendre MD, PhD
Ronald Ellis MD, PhD
Cristian Achim MD, PhD
Dan Duiculescu MD, PhD
Lumința Ene MD |
| 09:00-09:30 | Symposium Abbott Laboratories:
Evolution and dynamics of HIV-1 infection in the brain
Dan Duiculescu MD, PhD |
| 09:30-10:00 | Keynote lecture: Scott Letendre, MD, PhD
HIV Associated Neurocognitive Disorders |
| 10:00-10:15 | Keynote lecture: Luminița Ene, MD
Discussion on the evaluation algorithm of HIV associated complications in Romania |
| 10:15-10:30 | Q&A |
| 10:30-10:45 | Coffee break |
| 10:45-11:15 | Keynote lecture: Cristian Achim, MD, PhD
Clinical-pathological Correlations in HIV-associated Neurocognitive Disorders |
| 11:15-11:45 | Keynote lecture: Ronald Ellis, MD, PhD
HIV Related Peripheral Nervous System Disorders |
| 11:45-12:00 | Q&A |
| 12:00-12:45 | Session: NeuroHIV Screening
of neurocognitive disorders on HIV patients
Arbune Manuela
"Dunarea de Jos" University Galati
Considerations about risk
factors encountered in romanian HIV-infected patients diagnosed
with symptomatic peripheral neuropathies
Giubelan Lucian
University of Medicine and Pharmacy from Craiova, Romania
Pluri-microbial aggression in
CNS in HIV patients? Kibitzer or responsible? 5
case-reports
Ruxandra Moroti
The National Institute for Infectious Diseases Prof. Dr. Matei
Bals, Bucharest
|
| 12:45-13:00 | Closing remarks:
Adrian Streinu-Cercel, MD, PhD |
|